Adverse Hemodynamic Event Due to Floseal Hemostatic Matrix Application.
Department of Neuroanaesthesia National Institute of Mental Health and Neuro Sciences, Bangalore Karnataka, India.
Dhritiman
D
Chakrabarti
Gopala K K
GK
N
Dheeraj
D
Masapu
D058646:Adrenergic alpha-1 Receptor Agonists / Q000627:therapeutic use; D000328:Adult; D004618:Embolism, Air / Q000150:complications / Q000209:etiology* / Q000628:therapy; D005260:Female; D005440:Fluid Therapy; D005781:Gelatin Sponge, Absorbable / Q000009:adverse effects*; D018475:Head-Down Tilt; D006439:Hemodynamics / Q000187:drug effects*; D006487:Hemostasis / Q000187:drug effects; D006490:Hemostatics / Q000009:adverse effects*; D006801:Humans; D007022:Hypotension / Q000150:complications / Q000628:therapy; D008616:Mephentermine / Q000627:therapeutic use
D058646:Adrenergic alpha-1 Receptor Agonists; C411004:FloSeal Matrix; D006490:Hemostatics; D008616:Mephentermine